MedPath

Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

Not Applicable
Recruiting
Conditions
Childhood Cancer
Interventions
Other: Coronal calcium score measurement
Registration Number
NCT03604627
Lead Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Brief Summary

To measure coronary calcium score in adults treated during childhood or adolescence for irradiation cancer in the heart and / or anthracycline area and compare them to determine whether irradiation of the heart area is associated with increased calcium score after adjustment for other cardiovascular risk factors (age, sex, smoking, dyslipidemia, obesity, diabetes, high blood pressure and renal failure).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
500
Inclusion Criteria
  1. Patients 18 years of age or older,
  2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years),
  3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate) and / or anthracycline (cumulative dose of doxorubicin equivalent ≥300mg/m^²),
  4. In complete remission of their pediatric cancer for at least 10 years,
  5. Patient affiliated to a social security scheme or beneficiary of such a scheme,
  6. Patient Information and Signed Informed Consent.
Read More
Exclusion Criteria
  1. Perspective less than 10 years,
  2. Persons deprived of liberty or guardianship (including trusteeship),
  3. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons,
  4. Pregnant women.

Inclusion criteria for extension cohort:

  1. Patients 30 years of age or older,
  2. Treated for cancer during childhood, adolescence or young adulthood (≤25 years),
  3. Treated with irradiation of the heart area (≥20% of ≥5Gy heart rate),
  4. In complete remission of their pediatric cancer for at least 10 years,
  5. Patient affiliated to a social security scheme or beneficiary of such a scheme,
  6. Patient Information and Signed Informed Consent.

Exclusion criteria for extension cohort:

  1. Persons deprived of liberty or guardianship (including trusteeship),
  2. Impossibility of submitting to the medical follow-up of the test for geographical, social or psychological reasons,
  3. Pregnant women.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients treated for cancer during childhood or adolescenceCoronal calcium score measurementPatients over the age of 18 treated during childhood or adolescence for cancer with irradiation affecting the heart area (≥20% of ≥5Gy heart volume) and / or anthracyclines (≥ 300mg/m\^²)
Primary Outcome Measures
NameTimeMethod
Incidence of a calcium scoreUp to 24 months

Incidence of a calcium score measured by the Agatston score\> 0 in the study population of adults treated during childhood or adolescence for cancer with irradiation of the heart area and / or treatment with anthracyclines

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Hôpital Bichat

🇫🇷

Paris, France

Gustave Roussy

🇫🇷

Villejuif, Val De Marne, France

Hôpital Trousseau

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath